GeNeuro Secures European Patent For GNK-301 In ALS

GeNeuro, a subsidiary of NRx Pharmaceuticals (NRXP), secured European Patent EP 3 570 878 B1 covering GNK-301, an anti-HERV K antibody being developed for ALS. GNK-301 has shown neuroprotective effects in nonclinical models.